Processa Pharmaceuticals, Inc. (34) | Intellectual Property (8)

Browse by Subcategory

License Agreements (8)

Recent Contracts

Addendum No. 1 to the Aposense Ltd. License Agreement (Filed With SEC on March 25, 2021)
License Option Agreement with CoNCERT (Filed With SEC on September 17, 2020)
License Agreement with Akashi Therapeutics, Inc. dated August 29, 2019 (Filed With SEC on September 17, 2020)
License Agreement with Aposense, Ltd. dated May 24, 2020 (Filed With SEC on September 17, 2020)
License Agreement with Yuhan Corporation (Filed With SEC on September 17, 2020)
License Agreement with Elion Oncology, Inc (Filed With SEC on September 17, 2020)
License Agreement by and between Processa Pharmaceuticals and Elion Oncology dated August 23, 2020 (Filed With SEC on August 27, 2020)
License Agreement by and between Processa Pharmaceuticals, Inc. and Yuhan Corporation, dated August 19, 2020 (Filed With SEC on August 20, 2020)